Impact of smoking on the quantity and quality of antibodies induced by human papillomavirus type 16 and 18 AS04-adjuvanted virus-like-particle vaccine – a pilot study

BACKGROUND: The AS04-adjuvanted bivalent L1 virus-like-particle (VLP) vaccine (Cervarix™) against infection with human papillomavirus (HPV) types 16/18 holds great promise to prevent HPV16/18 infections and associated neoplasias, but it is important to rule out significant co-factors of the neoplasi...

Descripción completa

Detalles Bibliográficos
Autores principales: Namujju, Proscovia B, Pajunen, Emma, Simen-Kapeu, Aline, Hedman, Lea, Merikukka, Marko, Surcel, Helja-Marja, Kirnbauer, Reinhard, Apter, Dan, Paavonen, Jorma, Hedman, Klaus, Lehtinen, Matti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4105789/
https://www.ncbi.nlm.nih.gov/pubmed/25011477
http://dx.doi.org/10.1186/1756-0500-7-445

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4105789/
https://www.ncbi.nlm.nih.gov/pubmed/25011477
http://dx.doi.org/10.1186/1756-0500-7-445

Ejemplares similares